Impact of Ivabradine on Health-Related Quality of Life of Patients with Ischaemic Chronic Heart Failure

摘要

Objective: Chronic heart failure (CHF) remains a major health problem, with high levels of morbidity and mortality and a low health-related quality of life (HRQoL). We assessed the impact on HRQoL of adding the If channel blocker, ivabradine, to a standard treatment regimen of patients with ischaemic CHF (I-CHF) and heart rate (HR) >= 70 beats/min (bpm).